Literature DB >> 10491442

Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

Y Ando, T Tateishi, Y Sekido, T Yamamoto, T Satoh, Y Hasegawa, S Kobayashi, Y Katsumata, K Shimokata, H Saito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10491442     DOI： 10.1093/jnci/91.18.1587

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  14 in total

Review 1.  Cytochrome P450 3A and their regulation.

Authors:  Oliver Burk; Leszek Wojnowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-21       Impact factor: 3.000

Review 2.  Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

Authors:  Christine E Staatz; Lucy K Goodman; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

Review 3.  Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients.

Authors:  Alessio Provenzani; Andrew Santeusanio; Erin Mathis; Monica Notarbartolo; Manuela Labbozzetta; Paola Poma; Ambra Provenzani; Carlo Polidori; Giovanni Vizzini; Piera Polidori; Natale D'Alessandro
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

4.  Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.

Authors:  An Wang; Bang-Ning Yu; Chen-Hui Luo; Zhi-Rong Tan; Gan Zhou; Lian-Sheng Wang; Wei Zhang; Zhi Li; Jie Liu; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2005-01-14       Impact factor: 2.953

5.  Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania.

Authors:  Eva Maria Staehli Hodel; Chantal Csajka; Frédéric Ariey; Monia Guidi; Abdunoor Mulokozi Kabanywanyi; Socheat Duong; Laurent Arthur Decosterd; Piero Olliaro; Hans-Peter Beck; Blaise Genton
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

6.  Molecular mechanisms involving prostate cancer racial disparity.

Authors:  David Hatcher; Garrett Daniels; Iman Osman; Peng Lee
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

7.  Pharmacogenetic pathway analysis of docetaxel elimination.

Authors:  S D Baker; J Verweij; G A Cusatis; R H van Schaik; S Marsh; S J Orwick; R M Franke; S Hu; E G Schuetz; V Lamba; W A Messersmith; A C Wolff; M A Carducci; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2008-05-28       Impact factor: 6.875

8.  Polymorphisms and phenotypic analysis of cytochrome P450 3A4 in the Uygur population in northwest China.

Authors:  Tianbo Jin; Hua Yang; Jiayi Zhang; Zulfiya Yunus; Qiang Sun; Tingting Geng; Chao Chen; Jie Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.

Authors:  Charles M Rudin; Wanqing Liu; Apurva Desai; Theodore Karrison; Xuemin Jiang; Linda Janisch; Soma Das; Jacqueline Ramirez; Balasubramanian Poonkuzhali; Erin Schuetz; Donna Lee Fackenthal; Peixian Chen; Deborah K Armstrong; Julie R Brahmer; Gini F Fleming; Everett E Vokes; Michael A Carducci; Mark J Ratain
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

Review 10.  Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Authors:  Charnita M Zeigler-Johnson; Elaine Spangler; Mohamed Jalloh; Serigne M Gueye; Hanna Rennert; Timothy R Rebbeck
Journal:  Can J Urol       Date:  2008-02       Impact factor: 1.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.